GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $21,322,000 | +25.0% | 391,862 | +0.1% | 0.08% | +38.9% |
| Q1 2022 | $17,060,000 | -1.9% | 391,636 | -0.7% | 0.05% | +8.0% |
| Q4 2021 | $17,390,000 | +9.9% | 394,341 | -4.8% | 0.05% | -3.8% |
| Q3 2021 | $15,829,000 | -6.6% | 414,262 | -2.7% | 0.05% | +10.6% |
| Q2 2021 | $16,954,000 | +11.9% | 425,758 | +0.3% | 0.05% | +6.8% |
| Q1 2021 | $15,150,000 | +2.5% | 424,496 | +5.7% | 0.04% | -6.4% |
| Q4 2020 | $14,778,000 | -3.6% | 401,577 | -1.4% | 0.05% | -29.9% |
| Q3 2020 | $15,326,000 | -21.7% | 407,162 | -15.2% | 0.07% | -24.7% |
| Q2 2020 | $19,578,000 | +1.7% | 479,976 | -5.5% | 0.09% | -9.2% |
| Q1 2020 | $19,244,000 | -11.6% | 507,880 | +9.7% | 0.10% | +10.1% |
| Q4 2019 | $21,764,000 | +6.5% | 463,171 | -3.2% | 0.09% | -3.3% |
| Q3 2019 | $20,428,000 | +32.1% | 478,624 | +23.8% | 0.09% | +35.3% |
| Q2 2019 | $15,466,000 | -5.7% | 386,468 | -1.5% | 0.07% | -9.3% |
| Q1 2019 | $16,393,000 | +5.9% | 392,270 | -3.1% | 0.08% | -5.1% |
| Q4 2018 | $15,474,000 | -17.1% | 404,980 | -12.9% | 0.08% | -1.2% |
| Q3 2018 | $18,675,000 | -3.7% | 464,887 | -3.4% | 0.08% | -5.9% |
| Q2 2018 | $19,398,000 | +2.9% | 481,222 | -0.3% | 0.08% | +9.0% |
| Q1 2018 | $18,852,000 | +230.8% | 482,529 | +200.3% | 0.08% | +200.0% |
| Q4 2017 | $5,699,000 | -10.1% | 160,669 | +2.9% | 0.03% | -13.3% |
| Q3 2017 | $6,341,000 | -68.5% | 156,178 | -66.5% | 0.03% | -65.1% |
| Q2 2017 | $20,105,000 | +9.2% | 466,253 | +6.7% | 0.09% | +45.8% |
| Q1 2017 | $18,418,000 | +9.3% | 436,867 | -0.2% | 0.06% | -6.3% |
| Q4 2016 | $16,858,000 | -10.3% | 437,754 | +0.5% | 0.06% | -17.1% |
| Q3 2016 | $18,787,000 | -0.2% | 435,590 | +0.2% | 0.08% | -8.4% |
| Q2 2016 | $18,833,000 | +39.9% | 434,538 | +30.9% | 0.08% | +31.7% |
| Q1 2016 | $13,466,000 | +1.9% | 332,078 | +1.4% | 0.06% | -6.0% |
| Q4 2015 | $13,210,000 | +29.1% | 327,384 | +23.0% | 0.07% | +31.4% |
| Q3 2015 | $10,231,000 | -0.7% | 266,093 | +7.6% | 0.05% | +13.3% |
| Q2 2015 | $10,304,000 | -13.6% | 247,385 | -4.2% | 0.04% | -8.2% |
| Q1 2015 | $11,922,000 | +15.9% | 258,335 | +7.4% | 0.05% | +25.6% |
| Q4 2014 | $10,284,000 | -7.4% | 240,629 | -0.4% | 0.04% | -2.5% |
| Q3 2014 | $11,104,000 | +42.9% | 241,556 | +66.3% | 0.04% | +48.1% |
| Q2 2014 | $7,768,000 | +41.4% | 145,246 | +41.2% | 0.03% | +28.6% |
| Q1 2014 | $5,495,000 | +11.7% | 102,845 | +11.6% | 0.02% | +5.0% |
| Q4 2013 | $4,920,000 | +6.6% | 92,146 | +0.2% | 0.02% | +5.3% |
| Q3 2013 | $4,616,000 | +3.5% | 92,002 | +3.1% | 0.02% | -5.0% |
| Q2 2013 | $4,461,000 | – | 89,266 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |